Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Meta-analyses of these and other studies have demonstrated: Reductions in total cholesterol typically in the range of 15% from baseline, varying by agent and population Decreases in LDL cholesterol ranging from 17%, generally more modest than dedicated lipid-lowering therapies Reductions in triglycerides of 515%, with greater effects often seen in those with higher baseline levels Variable effects on HDL cholesterol , with small increases (1-2%) or neutral effects reported The magnitude of lipid improvements appears to correlate with the degree of weight loss achieved, suggesting that metabolic benefits may be partially mediated through adiposity reduction
It fights free radicals and detoxifies cells
PLoS One 10: e0136612 Chen Y, Tang Y, Zhang YC, Huang XH, Xie YQ, Xiang Y (2015) A metabolomic study of rats with doxorubicininduced cardiomyopathy and Shengmai injection treatment
Mitopure (Urolithin A), for example, enhances mitochondrial function through a process called mitophagy and is clinically proven to improve muscle strength, even in the absence of exercise
